Health expert shares drug with 'hopeful' signs of 'potentially reducing cancer'

Dr Tyna Moore said some people have described Ozempic as
-Credit: (Image: The Diary Of A CEO/YouTube)

A physician has claimed that a controversial diabetes drug has demonstrated "really hopeful" signs in terms of "potentially reducing cancer" in some unpublished studies.

The naturopathic and chiropractic physician, an expert in holistic regenerative medicine, Dr Tyna Moore, explored the potential health benefits of Ozempic while speaking with Steven Bartlett on his Diary of a CEO podcast this week.

She revealed that despite some critics branding Ozempic as "evil", it actually possesses "mind-blowing" health benefits, causing "really profound changes" in people, potentially even targeting cancers from which patients "don't come back from readily".

Later in the discussion, Dr Moore noted: "There are other data sets coming out that haven't been published yet are showing really good, really hopeful and positive impacts on potentially reducing cancer risk.

"And they're correlative, not causative, so we can't put our finger on it and say these reduce cancer, but they looked at a, you know, over a million people that were type 2 diabetics that were on semaglutide," reports the Express.

Dr Moore is a naturopathic and chiropractic physician and expert in holistic regenerative medicine
Dr Moore is a naturopathic and chiropractic physician and expert in holistic regenerative medicine -Credit:The Diary Of A CEO/YouTube

She clarified that it can't definitively be stated these reduce cancer, but they examined more than a million type 2 diabetes patients who were taking semaglutide.

In conclusion, Dr Moore stated: "And they found a significant reduction in different types of cancer that are obesity related in comparison to the folks who were not taking GLP-1s.

"And those were the cancers you don't want - the ovarian, the pancreatic, the colon, the types of cancers that are, you know, you don't come back from readily, and so that's very exciting."

Ozempic, a brand name for semaglutide and commonly used in diabetes treatment, has been making headlines due to its off-label use for weight loss, despite not being licensed for this purpose in the UK.

However, another semaglutide medication, Wegovy, is approved by the National Institute for Health and Care Excellence (NICE) for obesity management, as per NHS Kent and Medway.

Dr Moore told Steven Bartlett many people were being
Dr Moore told Steven Bartlett many people were being "overdosed for weight-loss" -Credit:The Diary Of A CEO/YouTube

The drug has gained popularity among celebrities like Rebel Wilson and Sharon Osbourne, who reportedly used it for weight loss, leading to a surge in demand across the UK.

Earlier this year, pharmacies reported a more than 400 per cent increase in consultations from individuals seeking access to these drugs.

This spike in demand is believed to be driven by research indicating that overweight heart disease patients who took semaglutide for at least three years reduced their risk of heart attack, stroke, or cardiac death by a fifth.

However, Ozempic is not without controversy. Reported side effects include nausea when thinking about food, potential links to pancreatitis, gallstones and a possible risk of thyroid cancer, as reported by Sky News in 2022.

Despite this, Dr Moore suggests that many people are being "overdosed for weight-loss" and believes the drug could have benefits for a range of serious health conditions.

She remarked: "What I was finding in the literature was not at all adding up to what I was hearing, and then there were all of these other benefits that were just mind-blowing."

Dr Moore elaborated: "You know, benefits on healing and reversing type 1 diabetes, healing and reversing neurocognitive conditions like Parkinson's and Alzheimer's, efficacy with alcohol cessation.

"People who were you know, alcohol abuse syndrome, using it for that. People who also had this type of HLA-B27; it's a genetic propensity towards these, spondyloarthritises like psoriatic arthritis, rheumatoid arthritis, those kinds of things.

"Having, showing efficacy for that, and as I started speaking out about it, I was getting messages back from people, telling me their stories, hundred and hundreds of people telling me their stories."